Paper36958362
Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study.
Man KKC and 22 others. Lancet Psychiatry, 2023. Cited by 66 papers, by iCite.
Cite this record
ConductScience Library. Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study. Papers, record 36958362. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36958362
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Methylphenidate | Major topic |
| Attention Deficit Disorder with Hyperactivity | Major topic |
| Central Nervous System Stimulants | Major topic |
| Child | |
| Adolescent | |
| Humans | |
| Male | |
| Female | |
| Psychotropic Drugs | |
| Germany | |
| Treatment Outcome |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 36958361 | Long-term safety of methylphenidate in children with ADHD. | https://conductscience.org/library/papers/36958361 |
Source PubMed
Cited by41
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42656627 | Disproportionality analysis of methylphenidate-associated adverse events in pediatric patients using the FDA Adverse Event Reporting System: overall signals and stratification by gender and dosage form. | Front Psychiatry | 2026 | https://conductscience.org/library/papers/42656627 | PubMed |
| 42627426 | Clinical practices in ADHD management across Europe: findings from the ESCAP research academy survey. | Eur Child Adolesc Psychiatry | 2026 | https://conductscience.org/library/papers/42627426 | PubMed |
| 42564791 | Self-reported ADHD symptoms among pharmacy students: prevalence of positive ADHD symptom screening, academic correlates, and implications for educational support. | Front Psychiatry | 2026 | https://conductscience.org/library/papers/42564791 | PubMed |
| 42469203 | Effects of methylphenidate on the human vascular endothelium. | Transl Psychiatry | 2026 | https://conductscience.org/library/papers/42469203 | PubMed |
| 42415397 | A Randomised Open-Label Comparison of Dexamphetamine and Methylphenidate in Children With Attention Deficit Hyperactivity Disorder (ADHD): Symptom Response, Adherence and Weight Impact Over 12 Months. | J Paediatr Child Health | 2026 | https://conductscience.org/library/papers/42415397 | PubMed |
| 42199906 | Effect of methylphenidate on physical growth indicators in children and adolescents with attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. | Front Psychiatry | 2026 | https://conductscience.org/library/papers/42199906 | PubMed |
| 42168718 | The Evolving Pharmacological Landscape for Paediatric and Adult ADHD. | CNS Drugs | 2026 | https://conductscience.org/library/papers/42168718 | PubMed |
| 42083867 | Psychiatric safety of methylphenidate in adults with major depressive disorder: a 1-year retrospective cohort study of 6,422 patients. | Psychol Med | 2026 | https://conductscience.org/library/papers/42083867 | PubMed |
| 41769062 | Severe self-limiting acute bilateral hearing loss following a low dose of methylphenidate for ADHD treatment: A case report. | PCN Rep | 2026 | https://conductscience.org/library/papers/41769062 | PubMed |
| 41627718 | Tolerance and Tachyphylaxis to Medications for Attention-Deficit/Hyperactivity Disorder (ADHD): A Systematic Review of Empirical Studies. | CNS Drugs | 2026 | https://conductscience.org/library/papers/41627718 | PubMed |
| 41490109 | ADHD and Methylphenidate Use in Prepubertal Children and BMI and Height at Adulthood. | JAMA Netw Open | 2026 | https://conductscience.org/library/papers/41490109 | PubMed |
| 41185813 | The Neuropsychology of Chronic Neurological Disorders: A Review of Cognitive and Emotional Impairments. | Cureus | 2025 | https://conductscience.org/library/papers/41185813 | PubMed |
| 41182374 | Use of methylphenidate and the risk of cardiovascular diseases in children and adolescents with a family history of heart diseases and congenital heart diseases: A self-controlled case series study. | Eur Child Adolesc Psychiatry | 2026 | https://conductscience.org/library/papers/41182374 | PubMed |
| 41112607 | Effects of attention-deficit hyperactivity disorder on growth in children and adolescents: A systematic review and meta-analysis. | World J Psychiatry | 2025 | https://conductscience.org/library/papers/41112607 | PubMed |
| 41099844 | Sex differences in the response to treatment of attention deficit hyperactivity disorder. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41099844 | PubMed |
| 40694311 | Current insights into the safety and adverse effects of methylphenidate in children, adolescents, and adults - narrative review. | Pharmacol Rep | 2025 | https://conductscience.org/library/papers/40694311 | PubMed |
| 40670510 | Clinical outcomes of a 12-week, first treatment with methylphenidate in an Italian representative sample of children and adolescents with ADHD. | Sci Rep | 2025 | https://conductscience.org/library/papers/40670510 | PubMed |
| 40629932 | Children and Young Adults Who Used Medication for Attention Deficit Hyperactivity Disorder Faced Increased Cardiac Risks. | Acta Paediatr | 2025 | https://conductscience.org/library/papers/40629932 | PubMed |
| 40332610 | Duration of ADHD medication treatment among Finnish children and adolescents ‒ a nationwide register study. | Eur Child Adolesc Psychiatry | 2025 | https://conductscience.org/library/papers/40332610 | PubMed |
| 40176288 | Prevalence of attention deficit hyperactivity disorder in homeless children and adolescents: A systematic review and meta-analysis. | Dialogues Clin Neurosci | 2025 | https://conductscience.org/library/papers/40176288 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36958362
GET https://conductscience.org/api/papers/v1/36958362/authors?page=2